Results 241 to 250 of about 62,863 (268)

Severe Pediatric Arterial Thrombosis in Antiphospholipid Syndrome and Systemic Lupus Erythematosus: A Case Report. [PDF]

Cureus
Jimenez I, Trelles Sanchez H, Gómez SS, Zuñiga González H, Llerena Vargas ME, Valverde Bonilla DGD, Valladares C.   +6 more
europepmc   +1 more source

Risk Factors for Recurrent Thrombosis in Patients with Antiphospholipid Syndrome-A Single-Centre Cohort Study. [PDF]

TH Open
Karandyszowska N, Faustini F, Alagündüz H, Widaeus J, Carlens F, Jensen AL, Oksanen A, Magnusson M, Gunnarsson I, Svenungsson E, Antovic A, Bruzelius M.   +11 more
europepmc   +1 more source

Simulation-based activated clotting time targeting for cardiopulmonary bypass in patients with antiphospholipid syndrome: two case reports. [PDF]

Gen Thorac Cardiovasc Surg Cases
Kamikawa Y, Saito Y, Fujii H, Machida Y, Hata H, Inaba H.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antiphospholipid syndrome

Clinical and Experimental Medicine, 2003
The antiphospholipid syndrome (APS) was reported in the early 1980s as the association of thrombosis, recurrent pregnancy loss in the presence of anticardiolipin antibodies (aCL) and/or lupus anticoagulant (LA). Since then, many other clinical manifestations have been associated with aPL.
M J, Cuadrado, C, Lopez-Pedrera
  +7 more sources

Antiphospholipid syndrome

Nature Reviews Disease Primers, 2018
This corrects the article DOI: 10.1038/nrdp.2017.103.
Schreiber K., Sciascia S., De Groot P. G., Devreese K., Jacobsen S., Ruiz-Irastroza G., Salmon J. E., Shoenfeld Y., Shovman O., Hunt B. J.   +9 more
openaire   +6 more sources

Antiphospholipid Syndrome

Pediatric Clinics of North America, 2005
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by a combination of arterial or venous thrombosis and recurrent fetal loss, accompanied by elevated titers of antiphospholipid antibodies (aPL). APS has been recognized as the leading cause of vascular thrombosis in children.
RAVELLI, ANGELO, MARTINI, ALBERTO
openaire   +3 more sources

Antiphospholipid syndrome

Current Opinion in Rheumatology, 2006
To review the recently published studies that can guide physicians in the management of persistently antiphospholipid antibody (aPL)-positive patients.Two recent prospective randomized controlled trials of two intensities of warfarin concluded that both moderate and high-intensity anticoagulation are similarly protective in antiphospholipid syndrome ...
Doruk, Erkan, Michael D, Lockshin
openaire   +2 more sources